<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02761941</url>
  </required_header>
  <id_info>
    <org_study_id>T80/2016</org_study_id>
    <nct_id>NCT02761941</nct_id>
  </id_info>
  <brief_title>Excessive Warfarin Anticoagulation - Causes and Consequences</brief_title>
  <acronym>EWA</acronym>
  <official_title>Excessive Warfarin Anticoagulation - Causes and Consequences</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Turku</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Turku</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to investigate the clinical significance of high INR (International
      Normalized Ratio) values (&gt;9) in VKA (vitamin K antagonist) treated patients with atrial
      fibrillation. The clinical characteristics of these patients will be studied as well as the
      clinical presentation. Factors influencing on high INR values will be recorded and the aim is
      to seek out patients who have elevated risk of bleeding complications.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a retrospective study setting. Source data will be collected by reviewing medical
      records and through computer searches. The basic study population will be identified from
      laboratory INR test results taken between 2003-2015.

      Identifying patients with INR values over 9 will be selected for further analysis, concerning
      the clinical presentation, patient characteristics, 90 day survival and adverse event rates.
      The focus is in identifying patient characteristics and factors influencing the risk of high
      INR value. Also we will analyse the effects of medically reversing the high INR values on
      stroke and other adverse event rates. The results will be collected manually using an
      electronic case report form, and analysed statistically using SPSS/SAS statistics tool.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
  </study_design_info>
  <target_duration>90 Days</target_duration>
  <primary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>90 days</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">25000</enrollment>
  <condition>Anticoagulation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients treated with VKA for atrial fibrillation in the Southwest Finland hospital
        district area with INR value over 9.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  VKA treatment, age &gt; 18, INR &gt;9,

        Exclusion Criteria:

          -  age &lt; 18
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Juhani Airaksinen, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Turku University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tuija Vasankari, RN</last_name>
    <phone>+358 2 3130900</phone>
    <email>tuija.vasankari@tyks.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juhani Airaksinen, prof</last_name>
      <phone>+35823131005</phone>
      <email>juhani.airaksinen@tyks.fi</email>
    </contact>
    <contact_backup>
      <last_name>Tuomas Kiviniemi, MD, PhD</last_name>
      <phone>+35823130787</phone>
      <email>tuoski@utu.fi</email>
    </contact_backup>
    <investigator>
      <last_name>Juhani Airaksinen, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tuomas Kiviniemi, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fausto Biancari, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Samuli Jaakkola, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ilpo Nuotio, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2016</study_first_submitted>
  <study_first_submitted_qc>May 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2016</study_first_posted>
  <last_update_submitted>May 4, 2016</last_update_submitted>
  <last_update_submitted_qc>May 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Turku</investigator_affiliation>
    <investigator_full_name>Juhani Airaksinen</investigator_full_name>
    <investigator_title>Professor of Cardiology</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Warfarin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

